Plasmodium falciparumDrug Resistance in Madagascar: Facing the Spread of Unusualpfdhfrandpfmdr-1Haplotypes and the Decrease of Dihydroartemisinin Susceptibility

Antimicrobial Agents and Chemotherapy
2009.0

Abstract

The aim of this study was to provide the first comprehensive spatiotemporal picture of Plasmodium falciparum resistance in various geographic areas in Madagascar. Additional data about the antimalarial resistance in the neighboring islands of the Comoros archipelago were also collected. We assessed the prevalence of pfcrt, pfmdr-1, pfdhfr, and pfdhps mutations and the pfmdr-1 gene copy number in 1,596 P. falciparum isolates collected in 26 health centers (20 in Madagascar and 6 in the Comoros Islands) from 2006 to 2008. The in vitro responses to a panel of drugs by 373 of the parasite isolates were determined. The results showed (i) unusual profiles of chloroquine susceptibility in Madagascar, (ii) a rapid rise in the frequency of parasites with both the pfdhfr and the pfdhps mutations, (iii) the alarming emergence of the single pfdhfr 164L genotype, and (iv) the progressive loss of the most susceptible isolates to artemisinin derivatives. In the context of the implementation of the new national policy for the fight against malaria, continued surveillance for the detection of P. falciparum resistance in the future is required.

Knowledge Graph

Similar Paper

Plasmodium falciparumDrug Resistance in Madagascar: Facing the Spread of Unusualpfdhfrandpfmdr-1Haplotypes and the Decrease of Dihydroartemisinin Susceptibility
Antimicrobial Agents and Chemotherapy 2009.0
Dynamics of Malaria Drug Resistance Patterns in the Amazon Basin Region following Changes in Peruvian National Treatment Policy for Uncomplicated Malaria
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro Sensitivities of Plasmodium falciparum to Different Antimalarial Drugs in Uganda
Antimicrobial Agents and Chemotherapy 2010.0
In Vitro Activities of Piperaquine, Lumefantrine, and Dihydroartemisinin in Kenyan Plasmodium falciparum Isolates and Polymorphisms in p fcrt and p fmdr1
Antimicrobial Agents and Chemotherapy 2009.0
Deamplification of pfmdr1 -Containing Amplicon on Chromosome 5 in Plasmodium falciparum Is Associated with Reduced Resistance to Artelinic Acid In Vitro
Antimicrobial Agents and Chemotherapy 2010.0
In Vitro Sensitivity of Plasmodium falciparum Clinical Isolates from the China-Myanmar Border Area to Quinine and Association with Polymorphism in the Na <sup>+</sup> /H <sup>+</sup> Exchanger
Antimicrobial Agents and Chemotherapy 2010.0
Genetic Analysis of the Dihydrofolate Reductase-Thymidylate Synthase Gene from Geographically Diverse Isolates of Plasmodium malariae
Antimicrobial Agents and Chemotherapy 2007.0
Role of Known Molecular Markers of Resistance in the Antimalarial Potency of Piperaquine and Dihydroartemisinin In Vitro
Antimicrobial Agents and Chemotherapy 2009.0
Defining the Role of Mutations inPlasmodium vivaxDihydrofolate Reductase-Thymidylate Synthase Gene Using an EpisomalPlasmodium falciparumTransfection System
Antimicrobial Agents and Chemotherapy 2010.0
Absence of Association between Piperaquine In Vitro Responses and Polymorphisms in the pfcrt , pfmdr1 , pfmrp , and pfnhe Genes in Plasmodium falciparum
Antimicrobial Agents and Chemotherapy 2010.0